Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project

References

• Gibbons S. ‘Legal highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist.Clin Toxicol (Phila) 2012;50:15–24.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012;8:33–42.
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report on the state of the drugs problem in Europe. 2012. http://www.emcdda.europa.eu/publications/annual-report/2012.
   Google Scholar
• Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 2011;201:191–5.
   PubMed Web of Science ®Google Scholar
• Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011;49:705–19.
   PubMed Web of Science ®Google Scholar
• Kronstrand R, Roman M, Thelander G, Eriksson A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol 2011;35:242–7.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of ‘bath salts’ and ‘legal highs’ (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011;49:499–505.
   PubMed Web of Science ®Google Scholar
• Baron M, Elie M, Elie L. An analysis of legal highs: do they contain what it says on the tin?Drug Test Anal 2011;3:576–81.
   PubMed Web of Science ®Google Scholar
• Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI. Purchasing ‘legal highs’ on the Internet – is there consistency in what you get?QJM 2010;103:489–93.
   PubMed Web of Science ®Google Scholar
• Zukiewicz-Sobczak W, Zwolinski J, Chmielewska-Badora J, Krasowska E, Piątek J, Sobczak P, Wojtyła A, Fornal E, Kuczumow A, Biliński P. Analysis of psychoactive and intoxicating substances in legal highs. Ann Agric Environ Med 2012;19:309–14.
   PubMed Web of Science ®Google Scholar
• Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 2011;5:60.
   PubMed Web of Science ®Google Scholar
• Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:234–43.
   PubMed Web of Science ®Google Scholar
• Davey Z, Schifano F, Corazza O, Deluca P. e-Psychonauts: conducting research in online drug forum communities. J Ment Health 2012;21:386–94.
   PubMed Web of Science ®Google Scholar
• Kjellgren A, Soussan C. Heaven and hell – a phenomenological study of recreational use of 4-HO-MET in Sweden. J Psychoactive Drugs 2011;43:211–9.
   PubMed Web of Science ®Google Scholar
• Murphy CM, Dulaney AR, Beuhler MC, Kacinko S.‘Bath Salts’ and ‘Plant Food’ products: the experience of one regional US poison center.J Med Toxicol 2013;9:42–8.
   PubMedGoogle Scholar
• Bell C, George C, Kicman AT, Traynor A. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test Anal 2011;3:496–504.
   PubMed Web of Science ®Google Scholar
• Björnstad K, Beck O, Helander A. A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:1162–8.
   PubMed Web of Science ®Google Scholar
• Nordgren HK, Beck O. Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS. Ther Drug Monit 2004;26:90–7.
   PubMed Web of Science ®Google Scholar
• Wohlfarth A, Weinmann W, Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem 2010;396: 2403–14.
   PubMed Web of Science ®Google Scholar
• Andersson M, Gustavsson E, Stephanson N, Beck O. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing. J Chromatogr B Analyt Technol Biomed Life Sci 2008;861:22–8.
   PubMed Web of Science ®Google Scholar
• Böttcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol 2008;43:46–8.
   PubMed Web of Science ®Google Scholar
• Gustavsson E, Andersson M, Stephanson N, Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. J Mass Spectrom 2007;42:881–9.
   PubMed Web of Science ®Google Scholar
• Stephanson N, Josefsson M, Kronstrand R, Beck O. Accurate identification and quantification of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of a direct high efficiency liquid chromatographic-mass spectrometric method. J Chromatogr B Analyt Technol Biomed Life Sci 2008;871: 101–8.
   PubMed Web of Science ®Google Scholar
• Arndt T, Claussen U, Gussregen B, Schröfel S, Stürzer B, Werle A, Wolf G. Kratom alkaloids and O-desmethyltramadol in urine of a ‘Krypton’ herbal mixture consumer. Forensic Sci Int 2011;208:47–52.
   PubMed Web of Science ®Google Scholar
• de Jager AD, Warner JV, Henman M, Ferguson W, Hall A. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine – an Australian perspective. J Chromatogr B Analyt Technol Biomed Life Sci 2012;897:22–31.
   PubMed Web of Science ®Google Scholar
• Hutter M, Broecker S, Kneisel S, Auwarter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques. J Mass Spectrom 2012;47:54–65.
   PubMed Web of Science ®Google Scholar
• Dargan PI, Davies S, Puchnarewicz M, Johnston A, Wood DM. First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam. Eur J Clin Pharmacol 2013;69:361–3.
   PubMed Web of Science ®Google Scholar
• Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data system in 2010. Ann Emerg Med 2012;60:435–8.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, Dargan PI. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010;48:924–7.
   PubMed Web of Science ®Google Scholar
• Ayres TC, Bond JW. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?. BMJ Open 2012; 2:e000977. DOI:10.1136/bmjopen-2012-000977.
   PubMed Web of Science ®Google Scholar
• Westwell AD, Hutchings A, Caldicott DG. The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel Emergency Department toxicosurveillance tool. Drug Test Anal 2013;5:203–7.
   PubMed Web of Science ®Google Scholar
• Helander A, Beck O, Hägerkvist R, Hulten P. STRIDA in the fight against il(legal) Internet drugs. Läkartidningen 2011;108:2312–5 [in Swedish].
   PubMedGoogle Scholar
• Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow .. and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.J Med Toxicol 2012;8:15–32.
   PubMedGoogle Scholar
• Simmons J, Cookman L, Kang C, Skinner C. Three cases of ‘spice’ exposure. Clin Toxicol (Phila) 2011;49:431–3.
   PubMed Web of Science ®Google Scholar
• Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother 2012;46:436–41.
   PubMed Web of Science ®Google Scholar